Latest news with #Reveal
Yahoo
19-05-2025
- Business
- Yahoo
TransPerfect Legal Announces Launch of Brainspace Integration for Reef Review
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- TransPerfect Legal, the global leader in legal technology, AI, and advisory services, today announced an integration between its Reef Review document review platform and Brainspace, Reveal's interactive data analytics and AI technology. This combined solution empowers organizations to streamline their document review process and make smarter, data-driven decisions faster. The integration of Brainspace with Reef Review enables lawyers to harness the power of continuous active learning, technology assisted review, email threading, and near-duplicate analysis to review vast datasets within Reef Review's intuitive user interface. Reveal CEO & Founder Wendell Jisa remarked, 'Our collaboration with TransPerfect Legal and Reef Review combines the industry's leading data analytics technology, Brainspace, with Reef Review's intuitive and user-friendly document review platform.' Key benefits of this integration include: Continuous Active Learning: Leverage active learning techniques along with human review to continuously train and prioritize document review. Technology Assisted Review: Use predictive scores to materially accelerate document review under 'TAR 1.0' or 'TAR 2.0' models. Email Threading: Automatically identify and organize email threads while suppressing 'lesser-included' emails to streamline the document review process. Near-Duplicate Identification: Seamlessly isolate near-duplicate documents for expedited review and analysis. TransPerfect President and Co-CEO Phil Shawe commented, 'Integrating TransPerfect Legal's Reef Review platform with Brainspace enables organizations to supercharge their document review workflow in the industry's fastest and most intuitive review platform.' About BrainspaceBrainspace is Reveal's leading AI-powered analytics platform specializing in data visualization, machine learning, and advanced data intelligence solutions. Trusted by enterprises worldwide, Brainspace empowers organizations with the tools they need to unlock the full potential of their data. For more information, please visit About TransPerfect LegalTransPerfect Legal is a global leader in legal technology, AI, and advisory services for Am Law 200 and Global 100 law firms as well as corporate legal departments. With offices in more than 140 cities worldwide, solutions include forensic technology and consulting, eDiscovery and early data assessment, managed review and legal staffing, language services, deposition and trial support, and paper discovery, all offered alongside the Reef Technology ecosystem, TransPerfect Legal's suite of proprietary applications that address the needs of legal and regulatory practitioners around the world. For more information, please visit About TransPerfectTransPerfect is the world's largest provider of language services and AI solutions for global business. From offices in over 140 cities on six continents, TransPerfect offers a full range of services in 200+ languages to clients worldwide. More than 6,000 global organizations employ TransPerfect's GlobalLink® technology to simplify the management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at Contact: Ryan Simper +1 212.689.5555mediainquiry@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-05-2025
- Business
- Yahoo
GH Q1 Earnings Call: Guardant Health Lifts Full-Year Guidance Following Oncology and Screening Momentum
Diagnostics company Guardant Health (NASDAQ:GH) announced better-than-expected revenue in Q1 CY2025, with sales up 20.8% year on year to $203.5 million. The company's full-year revenue guidance of $885 million at the midpoint came in 3.2% above analysts' estimates. Its non-GAAP loss of $0.49 per share was 17% above analysts' consensus estimates. Is now the time to buy GH? Find out in our full research report (it's free). Revenue: $203.5 million vs analyst estimates of $190.3 million (20.8% year-on-year growth, 6.9% beat) Adjusted EPS: -$0.49 vs analyst estimates of -$0.59 (17% beat) Adjusted EBITDA: -$58.54 million vs analyst estimates of -$78.16 million (-28.8% margin, 25.1% beat) The company lifted its revenue guidance for the full year to $885 million at the midpoint from $855 million, a 3.5% increase Operating Margin: -54.6%, up from -59.2% in the same quarter last year Free Cash Flow was -$67.15 million compared to -$37.22 million in the same quarter last year Sales Volumes rose 28.1% year on year (19.9% in the same quarter last year) Market Capitalization: $5.12 billion Guardant Health's first quarter results were driven by expanding adoption across its cancer diagnostics portfolio, particularly within its oncology and screening businesses. Management pointed to increased test volumes for both Guardant360 and Reveal, supported by product upgrades, Medicare reimbursement, and cost improvements. The company also highlighted growing demand for its Shield blood-based screening test, which achieved positive gross margin earlier than anticipated. Co-CEO Helmy Eltoukhy commented on the "strongest growth" seen in Guardant360 in several years, attributing gains to the upgraded smart liquid biopsy platform and new tissue product introductions. Looking ahead, Guardant Health raised its full-year revenue outlook, reflecting higher expectations for oncology and Shield test volumes. The company's guidance factors in incremental revenue from recently improved reimbursement rates, the expansion of its sales force, and the expectation of further gross margin improvements for new products. CFO Michael Bell noted that Shield's new ADLT status and positive reception in new markets, such as the VA Community Care Network, underpin the higher forecast, while management remains focused on reinvesting incremental profits to accelerate commercial infrastructure. Guardant Health's management attributed first quarter outperformance to increased oncology and screening test adoption, new product capabilities, and efficiency gains across its operations. Oncology test growth: Guardant360 volumes accelerated following last year's upgrade to the smart liquid biopsy platform, with the product experiencing its strongest sequential growth in years. The new Guardant360 Tissue test, requiring 40% less tissue and integrating DNA, RNA, and methylome analysis, was introduced as the final major product to migrate onto this platform. Reveal momentum: Reveal, Guardant's tissue-free MRD (minimal residual disease) test, continued to grow rapidly and reached gross margin positivity in Q1 due to a more than 50% reduction in cost per test and expanded Medicare coverage for colorectal cancer surveillance. Management expects additional clinical data and reimbursement for breast cancer applications later in the year. Shield screening traction: The Shield blood-based screening test generated increasing revenue and achieved positive gross margin ahead of plan. Key drivers included its inclusion under the VA Community Care Network and the acquisition of ADLT status, which increased Medicare reimbursement rates. Management noted strong physician and patient acceptance, especially among unscreened populations. Biopharma & data partnerships: The company reported another strong quarter for its Biopharma & Data division, highlighting an expanded collaboration with Pfizer and new real-world data partnerships with large pharma clients. These relationships support both companion diagnostic development and the use of Guardant's methylation analysis. Commercial investments and cost discipline: Gross margin gains were offset by higher sales and marketing expenses as the company accelerated the Shield commercial rollout and expanded its sales force—expected to reach 200 by year-end. Management underscored a continued focus on cash management and progress toward achieving company-wide cash flow breakeven by 2028. Guardant Health's outlook is driven by expectations for sustained volume growth in core oncology and screening products, continued reimbursement improvements, and expanded commercial reach. Oncology platform upgrades: Management believes expanded clinical utility, new product launches, and improved reimbursement across Guardant360, Reveal, and the new tissue test will continue to drive volume growth and market share gains in therapy selection and MRD applications. Shield screening expansion: Growth in Shield volumes is expected to accelerate as commercial infrastructure is built out, with contributions from new payor coverage, higher Medicare rates, and broader access through networks like the VA. Management cited inclusion in clinical guidelines and additional sales hires as potential upside drivers. Operational headwinds and reinvestment: While gross margin expansion is anticipated, higher operating expenses are expected as profits from successful products are reinvested to expand sales and marketing. Management also identified risks such as the timing of sales force productivity ramp-up and the pace of new account adoption. Mark Massaro (BTIG): Asked about the primary drivers of accelerating oncology volume and the relative contribution of EMR integration, competitive takeaways, and tissue product attachment. Management emphasized product upgrades and improved ordering simplicity as key contributors. Tycho Peterson (Jefferies): Inquired about the runway for further Guardant360 ASP (average selling price) improvements, guidance assumptions for tissue test pricing, and the steps needed to drive broader payer adoption for Shield's multi-cancer detection. Management expects stable ASPs and continued payer engagement based on new data. Bill Bonello (Craig-Hallum): Questioned the impact of the new tissue test requiring less material and whether this could lead to higher market share or cannibalization of blood-based testing. Management expects both modalities to grow, with guidelines increasingly supporting dual testing. Subbu Nambi (Guggenheim Partners): Sought clarity on potential upside and downside drivers to Shield's volume guidance, including the impact of guideline inclusion and the pace of sales force ramp. Management pointed to productivity gains and possible guideline inclusion as upside factors. Rachel Vatnsdal (JPMorgan): Pressed for specifics on the expected Shield volume ramp and whether sequential growth would accelerate throughout the year given the new sales hires. Management indicated growth would be weighted toward the second half as reps achieve full productivity. As we look to the coming quarters, the StockStory team will monitor (1) the pace of Shield screening adoption as new sales hires reach productivity, (2) the impact of guideline updates and expanded coverage on test volumes, and (3) progress toward broader reimbursement for Reveal in breast cancer and other indications. Execution on sales force expansion and new product launches will be key to sustaining the company's raised outlook. Guardant Health currently trades at a forward price-to-sales ratio of 5.5×. Should you load up, cash out, or stay put? See for yourself in our free research report. Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
06-05-2025
- Business
- Business Wire
LoopMe and Reveal Mobile Expand Partnership to Power Global Brand Lift Measurement for the Out-of-Home Industry
LONDON & NEW YORK--(BUSINESS WIRE)-- LoopMe, the global leader in brand performance, is proud to announce the expansion of its partnership with Reveal Mobile, establishing Reveal as LoopMe's dedicated partner for global Out-of-Home (OOH) brand lift measurement. The combined capabilities of Reveal and LoopMe provide a full-stack brand measurement solution purpose-built for the future of omnichannel media—grounded in transparency, innovation, and global scalability. This partnership leverages Reveal Mobile's deep category expertise and sophisticated exposure data capabilities to provide best-in-class brand lift studies tailored specifically for the unique dynamics of the OOH ecosystem. Reveal's recent expansion into nine European countries —including the United Kingdom, Germany, France, Italy, Spain, the Netherlands, Belgium, Sweden, and Austria—marks a significant milestone in this collaboration. With Reveal now able to deliver high-quality GPS-based exposure data at scale across these key markets, LoopMe's measurement platform can offer unprecedented levels of quality, accuracy, and consistency in brand lift reporting for OOH campaigns around the globe. 'Reveal's expansion into Europe is a game-changer for the OOH industry,' said Stephen Upstone, CEO and Founder, LoopMe. 'Their precision in audience curation and understanding of OOH formats provides the perfect data foundation for our measurement technology. Together, we're enabling more brands, agencies, and platform partners to measure real impact and outcomes across the OOH channel.' "We're thrilled to grow our partnership with LoopMe and bring our capabilities to new global markets,' said Brian Handly, CEO, Reveal Mobile. 'As Out-of-Home continues to evolve into a precision-driven, measurable channel, our collaboration ensures advertisers have the trusted insights they need to validate performance and optimize outcomes across borders.' LoopMe's patented methodology powers brand lift measurement through privacy-first, non-incentivized mobile surveys and proprietary control group matching. Built from the ground up for GDPR compliance, LoopMe's infrastructure aligns seamlessly with Reveal's commitment to responsible data collection and activation across the advertising ecosystem. For advertisers and partners who already possess their own exposure data, LoopMe independently supports brand lift measurement across 117 global markets. However, for clients who require expert-curated exposure data—especially in the highly diverse OOH landscape—Reveal serves as LoopMe's preferred data partner. From screen type and venue context to campaign flight and regional nuances, Reveal's data enrichment process ensures LoopMe studies are precisely calibrated to reflect the intricacies of the medium. 'This partnership is about enabling better measurement outcomes for the OOH space,' said Solomon Gezari, Senior Director of Partnerships, LoopMe. 'OOH comes with a broad variety of formats, venues, and contextual variables, and Reveal brings the expertise necessary to ensure we're capturing meaningful, accurate, and actionable insights for our clients.' The combined capabilities of Reveal and LoopMe provide a full-stack brand measurement solution purpose-built for the future of omnichannel media—grounded in transparency, innovation, and global scalability. For more information about LoopMe's OOH brand lift measurement or to initiate a study, please contact: amp@ About LoopMe LoopMe is the global leader in brand performance, redefining brand advertising for the digital and app ecosystem. LoopMe was the first to apply AI to brand advertising and its Intelligent Marketplace, finding solutions to industry challenges that haven't previously been solved. With consumer insights and AI at its core, LoopMe makes brand advertising better, outperforming industry benchmarks for leading global brands. LoopMe's acquisition of Chartboost underscores its commitment to expand its capabilities and reinforces its position as the leading AI-powered brand advertising and performance platform. Our vision is to change advertising for the better, by building technology that will redefine brand advertising. LoopMe was founded in 2012 and is headquartered in the UK, with global offices across New York, Boston, Atlanta, Chicago, Detroit, San Francisco, Los Angeles, Toronto, Singapore, Sydney, Melbourne, Dnipro, Krakow, Beijing, Shanghai and Hong Kong. For more information, please visit About Reveal Mobile Reveal Mobile is the leading provider of Out-of-Home (OOH) advertising campaign performance measurement. Mira Studies from Reveal were the first to measure OOH advertising's impact on foot traffic, in-app purchases, and web based activity (and since expanded to include brand awareness). Reveal Mobile has expertise in measuring all types of OOH including programmatic, place based, and moving. Reveal Mobile also measures foot traffic attribution for digital media through its proprietary VISIT Local product. The company is based in Raleigh, NC and New York, NY. For more information, please visit
Yahoo
30-04-2025
- Business
- Yahoo
Canam Steel Corporation Enters Multi-Residential Market with Acquisition of Vescom Floor System
Composite floor system to anchor CSC's newly created Building Solutions team POINT OF ROCKS, Md., April 30, 2025 /PRNewswire/ -- Canam Steel Corporation (CSC), a U.S.-based manufacturer of custom-engineered steel building product solutions, has announced the acquisition of Vescom International, a New York-based developer of an innovative composite floor system for multi-story structures. Now rebranded as the Vescom Floor System, this proven product line will be offered as part of CSC's newly established Building Solutions group. Originally developed in 1982, the Vescom Floor System has been installed on hundreds of projects across North America. Designed for speed, strength and safety, the system is a preferred choice for residential, commercial, and institutional buildings—including senior living facilities, student housing, medical facilities, and high-rise apartments and condominiums. "Adding the Vescom Floor System to our portfolio strengthens our ability to provide versatile, high-performance solutions for complex, multi-story projects," said Brad Lazorka, CEO of Canam Steel Corporation. "We're excited to offer a product that has long been trusted in the industry and carry it forward with the engineering excellence, reliability, and customer-first mindset that CSC is known for." The Vescom Floor System integrates custom-fabricated steel joists and decking with site-applied mesh and concrete. Its distinctive inverted top chord forms a mechanical bond with the concrete slab, resulting in a stronger connection, reduced deflection and bounce, greater overall stiffness, and a faster, cleaner installation. No shoring or temporary forms are required, making it one of the most efficient and effective floor systems available. The acquisition also marks the debut of CSC's Building Solutions team - a dedicated arm of the business that supports multi-residential construction projects. In addition to the Vescom Floor System, they will offer the Reveal [Dovetail] Floor System, and standard deck options utilized over light gage walls or other means of multi-residential construction. The Building Solutions team is led by Sales Manager Rick Armando, a seasoned industry professional focused on helping customers navigate complex jobsite requirements with collaborative, custom steel solutions. With six manufacturing facilities across the country, CSC is a trusted partner to builders nationwide. The company's in-house engineering, fabrication, and project management teams work in lockstep to solve challenges and ensure success from concept to completion. For more information about the Vescom Floor System or CSC's full range of steel solutions, visit About Canam Steel Corporation:Canam Steel Corporation (CSC) is a national leader in custom-engineered steel joists, deck products, and building solutions for commercial and multi-residential construction. With six strategically located facilities serving clients in all 50 states, CSC is known for delivering projects on time, embracing complexity, and forging strong customer partnerships. Backed by expert engineering, personalized service, and a commitment to safety and quality, CSC creates collaborative solutions that bring complex projects to life. Learn more at View original content to download multimedia: SOURCE Canam Steel Corporation Sign in to access your portfolio
Malaysian Reserve
24-04-2025
- Business
- Malaysian Reserve
Introducing Orlandi's EcoPro™ Paper Label designed for Fragrance Sampling
FARMINGDALE, N.Y., April 23, 2025 /PRNewswire/ — Orlandi is proud to announce the launch of its eco-friendly paper label, designed specifically for perfume and scent sampling. This innovative product is set to advance sustainability and recyclability of fragrance samples and allow brands to advertise their products in an ecologically responsible and effective manner. Unlike many other products in the market, EcoPro™ labels are crafted from paper, without the use of plastic and foil. Designed to deliver a true rendition of the fragrance using Orlandi's Reveal fragrance technology, EcoPro™ labels are cost-effective, versatile in design, and serve as an effective way to reach consumers through point of sale handouts, direct mail communications, co-ship e-commerce samples, or as inserts in catalogs and magazines. 'We are thrilled to introduce the EcoPro™ Sampling Technology to the market,' said Sven Dobler, CEO of Orlandi.' 'Our goal is to provide a sustainable solution for fragrance sampling that does not compromise quality, aesthetics or performance. This product is a testament to our commitment to innovation and environmental stewardship.' The launch of the EcoPro™ label aligns with Orlandi's ongoing efforts to reduce environmental impact and promote sustainable practices within the industry. By choosing this eco-friendly option, brands can enhance their sustainability credentials while delivering an exceptional sampling experience to consumers. For more information about Orlandi's paper-based fragrance label, visit About Orlandi:Orlandi is a leading international supplier of over 25 different fragrance and cosmetic sampling solutions to the beauty and consumer products sector, as well as a provider of contract packaging, filling, design, and turnkey manufacturing services for home and air care applications. Orlandi is family-owned and operated, with roots dating to 1865, and continues to build value for its stakeholders through excellence in research, innovation, sustainable product design, superior quality, and customer service. Orlandi is headquartered in Farmingdale, NY USA, and has operational facilities and laboratories in the United States, France, and Brazil.
